Conference Coverage
Conference Coverage
VIDEO: No effect of BRCA status on overall outcomes in early-onset breast cancer
SAN ANTONIO – No difference in outcomes was seen among young BRCA gene mutation carriers and noncarriers with early stage invasive breast cancer...
Conference Coverage
No boost in pCR from neoadjuvant estrogen deprivation
Estrogen deprivation added to chemotherapy and dual HER2 inhibition did not improve pathologic complete responses, compared with chemotherapy...
Conference Coverage
VIDEO: No improvement in pCR with dual ER and HER2 inhibition
SAN ANTONIO
Conference Coverage
Optimal duration of extended AI therapy? Flip a coin
SAN ANTONIO – The optimal duration of aromatase inhibitor therapy following 5 years of endocrine therapy in postmenopausal women is still unknown...
Conference Coverage
Next-generation sequencing highlights evolution of ER+ breast cancer
The “genomic landscape” of resistant estrogen receptor–positive metastatic breast cancer differs significantly from that of ER+ primary breast...
Conference Coverage
VIDEO: Veliparib misses PFS endpoint, advances to phase III trial
SAN ANTONIO – Veliparib failed to significantly improve progression-free or overall survival when added to carboplatin and paclitaxel in patients...
Conference Coverage
Fulvestrant/everolimus improves PFS in HR+, HER2– advanced breast cancer
SAN ANTONIO – Adding everolimus to fulvestrant doubled median progression-free survival among postmenopausal women with hormone-receptor positive...
Conference Coverage
VIDEO: Investigator discusses fulvestrant/everolimus combo
SAN ANTONIO – Most women with hormone receptor–positive breast cancer treated with an aromatase inhibitor will eventually develop resistance to...
Conference Coverage
SABCS 2016: Top picks from Dr. Hope S. Rugo and Dr. William J. Gradishar
Oncology Practice associate editors Dr. Hope S. Rugo and Dr. William J. Gradishar reveal several anticipated studies from the 39th annual San...
Conference Coverage
Optimal MPE management requires early pulmonology referral
LOS ANGELES – About half of patients with symptomatic malignant pleural effusions at McGill University Health Centre in Montreal had unnecessary...